Hardik I. Parikh

2.6k citations

36 papers · 821 indexed · h-index 18

Co-authors: Glen E. Kellogg Gregory A. Buck Nihar U. Sheth Katie E. Barry Amy J. Mathers Shireen Kotay Tai L. Guo Vishal N. Kopardé
Topics: Antibiotic Resistance in Bacteria (10 papers)Genomics and Phylogenetic Studies (6 papers)Reproductive tract infections research (4 papers)
Cited by: Molecular Medicine Endocrinology Microbiology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations: United States United Kingdom China

In The Last Decade

Hardik I. Parikh

34 papers receiving 809 citations

Peers

Countries citing papers authored by Hardik I. Parikh

Since Specialization

Citations

This map shows the geographic impact of Hardik I. Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hardik I. Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hardik I. Parikh more than expected).

Fields of papers citing papers by Hardik I. Parikh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hardik I. Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hardik I. Parikh. The network helps show where Hardik I. Parikh may publish in the future.

Co-authorship network of co-authors of Hardik I. Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Hardik I. Parikh. A scholar is included among the top collaborators of Hardik I. Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hardik I. Parikh. Hardik I. Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Developing a framework for tracking antimicrobial resistance gene movement in a persistent environmental reservoir 2024 ·SHILAP Revista de lepidopterología ·Amy J. Mathers,(unknown),(unknown),(unknown),Nicole Stoesser,David W. Eyre,Andrew Walker,Katie E. Barry,(unknown),Fenix W. D. Huang,Hardik I. Parikh,Shireen Kotay,Derrick W. Crook,Christian M. Reidys	2
2	Tracking Klebsiella pneumoniae carbapenemase gene as an indicator of antimicrobial resistance dissemination from a hospital to surface water via a municipal wastewater treatment plant 2022 ·Water Research ·(unknown),Shireen Kotay,Katie E. Barry,Hardik I. Parikh,Lisa M. Colosi,Amy J. Mathers	36
3	Genetic, epigenetic, and environmental factors controlling oxytocin receptor gene expression 2021 ·Clinical Epigenetics ·(unknown),(unknown),Andrew J. Graves,(unknown),Allison M. Perkeybile,William M. Kenkel,Travis S. Lillard,Hardik I. Parikh,Hudson Golino,Simon G. Gregory,C. Sue Carter,Karen L. Bales,Jessica J. Connelly	42
4	Nutrients influence the dynamics of Klebsiella pneumoniae carbapenemase producing enterobacterales in transplanted hospital sinks 2020 ·Water Research ·Shireen Kotay,Hardik I. Parikh,Katie E. Barry,Hyun S. Gweon,William H. Guilford,Joanne Carroll,Amy J. Mathers	21
5	The Role of fosA in Challenges with Fosfomycin Susceptibility Testing of Multispecies Klebsiella pneumoniae Carbapenemase-Producing Clinical Isolates 2019 ·Journal of Clinical Microbiology ·(unknown),Katie E. Barry,Heather L. Cox,Nicole Stoesser,Joanne Carroll,Kasi Vegesana,Shireen Kotay,Anna E. Sheppard,Alexander M. Wailan,Derrick W. Crook,Hardik I. Parikh,Amy J. Mathers	30
6	Don't overlook the little guy: An evaluation of the frequency of small plasmids co-conjugating with larger carbapenemase gene containing plasmids 2019 ·Plasmid ·Katie E. Barry,Alexander M. Wailan,Anna E. Sheppard,Derrick W. Crook,Kasi Vegesana,Nicole Stoesser,Hardik I. Parikh,Robert Sebra,Amy J. Mathers	33
7	Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence 2019 ·European Journal of Medicinal Chemistry ·Mohammad Anwar Hossain,(unknown),Hardik I. Parikh,Wei Li,Kendra P. Rumbaugh,Nadezhda German	23
8	Relationship between vitamin D status and the vaginal microbiome during pregnancy 2019 ·Journal of Perinatology ·Kimberly K. Jefferson,Hardik I. Parikh,(unknown),David Edwards,Myrna G. Serrano,Martin Hewison,Judith Shary,Anna Powell,Bruce W. Hollis,Jennifer M. Fettweis,Jerome F. Strauss,Gregory A. Buck,Carol L. Wagner	39
9	Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome 2019 ·The Journal of Infectious Diseases ·Marla J. Keller,Ashley Huber,(unknown),Myrna G. Serrano,Hardik I. Parikh,Gregory A. Buck,Jeremy A.W. Gold,Yiqun Wu,(unknown),Betsy C. Herold	18
10	Discovery of rare ancestry-specific variants in the fetal genome that confer risk of preterm premature rupture of membranes (PPROM) and preterm birth 2018 ·BMC Medical Genetics ·Bhavi P. Modi,Hardik I. Parikh,María E. Teves,(unknown),(unknown),Roberto Romero,Timothy P. York,Jerome F. Strauss	15
11	Genomic comparison of Trypanosoma conorhini and Trypanosoma rangeli to Trypanosoma cruzi strains of high and low virulence 2018 ·BMC Genomics ·Katie R. Bradwell,Vishal N. Kopardé,Andrey Matveyev,Myrna G. Serrano,João M. P. Alves,Hardik I. Parikh,Bernice Huang,Vladimir Lee,(unknown),Paola A. Ortíz,André G. Costa-Martins,Marta M. G. Teixeira,Gregory A. Buck	17
12	Rare mutations and potentially damaging missense variants in genes encoding fibrillar collagens and proteins involved in their production are candidates for risk for preterm premature rupture of membranes 2017 ·PLoS ONE ·Bhavi P. Modi,María E. Teves,Laurel N. Pearson,Hardik I. Parikh,Piya Chaemsaithong,Nihar U. Sheth,Timothy P. York,Roberto Romero,Jerome F. Strauss	16
13	MeFiT: merging and filtering tool for illumina paired-end reads for 16S rRNA amplicon sequencing 2016 ·BMC Bioinformatics ·Hardik I. Parikh,Vishal N. Kopardé,Steven Bradley,Gregory A. Buck,Nihar U. Sheth	71
14	Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP) 2016 ·Bioorganic & Medicinal Chemistry ·(unknown),Benjamin L. Morris,Hardik I. Parikh,(unknown),(unknown),Ian M. Love,Brendan J. Hilbert,William E. Royer,Glen E. Kellogg,Steven R. Grossman,Keith C. Ellis	21
15	Identification of Small-Molecule Inhibitors against Meso-2, 6-Diaminopimelate Dehydrogenase from Porphyromonas gingivalis 2015 ·PLoS ONE ·Victoria Stone,Hardik I. Parikh,(unknown),Xiuchun Ge,(unknown),Yan Zhang,Glen E. Kellogg,Ping Xu	14
16	Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL 2014 ·Antiviral Research ·(unknown),(unknown),Yali Zhu,(unknown),Deborah S. Parris,Hardik I. Parikh,Glen E. Kellogg,Alison Kuchta,Michael A. McVoy	19
17	Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolution 2013 ·Acta Crystallographica Section D Biological Crystallography ·Urszula Derewenda,Mykhaylo Artamonov,(unknown),Darkhan Utepbergenov,(unknown),Hardik I. Parikh,Glen E. Kellogg,Avril V. Somlyo,Zygmunt S. Derewenda	15
18	Biological Characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a Selective Sphingosine Kinase-2 Inhibitor and Anticancer Agent 2013 ·PLoS ONE ·Kai Liu,Tai L. Guo,Nitai C. Hait,Jeremy C. Allegood,Hardik I. Parikh,Wenfang Xu,Glen E. Kellogg,Steven Grant,Sarah Spiegel,Shijun Zhang	72
19	Intuitive, but not simple: Including explicit water molecules in protein–protein docking simulations improves model quality 2013 ·Proteins Structure Function and Bioinformatics ·Hardik I. Parikh,Glen E. Kellogg	13
20	3,5-Disubstituted-thiazolidine-2,4-dione analogs as anticancer agents: Design, synthesis and biological characterization 2011 ·European Journal of Medicinal Chemistry ·Kai Liu,Wei Rao,Hardik I. Parikh,Qianbin Li,Tai L. Guo,Steven Grant,Glen E. Kellogg,Shijun Zhang	84

About Hardik I. Parikh

Hardik I. Parikh is a scholar working on Molecular Medicine, Microbiology and Clinical Biochemistry, having authored 36 papers that have together received 821 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (10 papers), Genomics and Phylogenetic Studies (6 papers) and Reproductive tract infections research (4 papers). The work is most often cited by research in Molecular Medicine (172 citations), Endocrinology (79 citations) and Microbiology (68 citations). Hardik I. Parikh has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Glen E. Kellogg, Gregory A. Buck, Nihar U. Sheth, Katie E. Barry, Amy J. Mathers, Shireen Kotay, Tai L. Guo, Vishal N. Kopardé, Kai Liu and Steven Grant. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact